Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.

Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA.

Arthritis Care Res (Hoboken). 2012 Jun;64(6):826-32. doi: 10.1002/acr.21619. Epub 2012 Jan 19.

2.

The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).

Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM.

Value Health. 2011 Jul-Aug;14(5):732-9. doi: 10.1016/j.jval.2010.12.004. Epub 2011 May 6.

3.

Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.

Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W.

J Rheumatol. 2008 Apr;35(4):662-7. Epub 2008 Feb 15.

PMID:
18278836
4.

Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Kvamme MK, Kristiansen IS, Lie E, Kvien TK.

J Rheumatol. 2010 Jan;37(1):26-31. doi: 10.3899/jrheum.090449. Epub 2009 Dec 1.

PMID:
19955045
5.

Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.

J Rheumatol. 2011 Aug;38(8):1576-84. doi: 10.3899/jrheum.101006. Epub 2011 May 1.

PMID:
21532054
6.

Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.

Lillegraven S, Kristiansen IS, Kvien TK.

Ann Rheum Dis. 2010 Oct;69(10):1762-7. doi: 10.1136/ard.2009.124099. Epub 2010 May 6.

PMID:
20448285
7.

A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.

Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.

PMID:
21813061
8.

Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.

Ann Rheum Dis. 2012 Sep;71(9):1478-83. doi: 10.1136/annrheumdis-2011-200891. Epub 2012 Mar 14. Erratum in: Ann Rheum Dis. 2012 Oct;71(10):1756.

PMID:
22419775
9.

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.

Dritsaki M, Petrou S, Williams M, Lamb SE.

Health Qual Life Outcomes. 2017 Jan 24;15(1):20. doi: 10.1186/s12955-016-0584-6.

10.
11.

Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.

Kvamme MK, Lie E, Uhlig T, Moger TA, Kvien TK, Kristiansen IS.

Rheumatology (Oxford). 2015 Jul;54(7):1226-35. doi: 10.1093/rheumatology/keu460. Epub 2015 Jan 7.

PMID:
25573840
12.

Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.

Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M.

J Rheumatol. 2009 Jun;36(6):1209-16. doi: 10.3899/jrheum.081022. Epub 2009 Apr 15.

PMID:
19369452
13.

Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.

Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J.

Arthritis Rheum. 2007 Aug 15;57(6):1043-9.

14.

Comparison of EQ-5D and SF-6D utilities in mental health patients.

Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L.

Health Econ. 2006 Nov;15(11):1229-36.

PMID:
16625671
15.

Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.

Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F; Costs and Quality of Life in Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2006 Oct 15;55(5):751-6.

16.

Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.

Leung YY, Png ME, Wee HL, Thumboo J.

J Rheumatol. 2013 Jun;40(6):859-65. doi: 10.3899/jrheum.120782. Epub 2013 Mar 15.

PMID:
23504382
17.

Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.

Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M.

Pharmacoeconomics. 2010;28(6):477-87. doi: 10.2165/11533010-000000000-00000.

PMID:
20465316
18.

Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.

Chotai S, Parker SL, Sivaganesan A, Godil SS, McGirt MJ, Devin CJ.

Neurosurgery. 2015 Oct;77(4):553-60; discussion 560. doi: 10.1227/NEU.0000000000000886.

PMID:
26191977
19.

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.

Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH.

Soc Sci Med. 2005 Apr;60(7):1571-82.

PMID:
15652688
20.

Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.

Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA.

Ann Rheum Dis. 2008 Jun;67(6):789-93. Epub 2007 Nov 1.

PMID:
17974597

Supplemental Content

Support Center